Related Experiment Video
Updated: May 6, 2026
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Pentoxifylline therapy attenuates intestinal injury in rat pups with hypoxic ischemic encephalopathy
Salih Kalay1, Ali Islek, Armagan Ozturk
1Department of Pediatrics, Division of Neonatology .
Insights
Pentoxifylline (PTX) therapy significantly reduced gut injury in a neonatal rat model of hypoxic ischemic encephalopathy (HIE). This study shows PTX effectively mitigates intestinal damage following hypoxia/reoxygenation (H/R) injury.
Area of Science:
- Neonatal research
- Gastrointestinal pathology
- Neuroscience
Background:
- Hypoxic ischemic encephalopathy (HIE) is a major cause of neonatal brain injury.
- Gut injury is a common complication in HIE, impacting patient outcomes.
- Post-ischemic therapies are crucial for mitigating HIE-related damage.
Purpose of the Study:
- To investigate the therapeutic potential of pentoxifylline (PTX) in reducing gut injury.
- To evaluate PTX's efficacy in a neonatal rat model of HIE.
- To assess the impact of PTX on hypoxia/reoxygenation (H/R)-induced intestinal damage.
Main Methods:
- A neonatal rat model of HIE was established using 7-day-old Wistar pups.
- Animals were divided into control, hypoxia, and pentoxifylline (PTX) + hypoxia groups.
- Histopathological injury scores (HIS) were used to quantify intestinal injury 24 hours post-treatment.
Main Results:
- Hypoxia/reoxygenation (H/R) significantly increased intestinal injury scores compared to controls.
- PTX treatment significantly attenuated H/R-induced intestinal injury.
- PTX demonstrated a protective effect against gut damage in the HIE model.
Conclusions:
- Post-ischemic pentoxifylline (PTX) therapy effectively reduces H/R-induced intestinal injury in neonatal rats.
- PTX shows promise as a therapeutic agent for mitigating gut complications in HIE.
- These findings support further investigation into PTX for HIE management.
Aim:
The aim of this study was to evaluate the effects of post-ischemic pentoxifylline (PTX) therapy on the gut injury in neonatal rat model of hypoxic ischemic encephalopathy (HIE).
Methods:
Seven-day-old Wistar rat pups (n = 24) of either sex, delivered spontaneously, were used in this experimental study. Seven-day-old rat pups were randomly divided into three groups. Control group (n = 8): after median neck incision was made, neither ligation nor hypoxia was performed. Hypoxia group (n = 8): 0.5 ml of saline was injected intraperitoneally immediately after hypoxia. Pentoxifylline + Hypoxia group (n = 8): the rat pups were administered intraperitoneally 60 mg/kg of PTX immediately after hypoxia. Eight rats from all groups were sacrificed 24 h after drug administration. The ischemic injury was scored at least six sections at three different levels using histopathologic injury scores (HIS).
Results:
Induction of hypoxia/reoxygenation (H/R) increased mean HIS levels significantly at 24 h in the intestinal tissue samples in the hypoxia group as compared with the control group. Induction of H/R decreased means HIS levels significantly at 24 h in the intestinal tissue samples in the PTX + hypoxia group as compared with the hypoxia group.
Conclusion:
In this experimental study, PTX significantly attenuated H/R-induced intestinal injury in neonatal rat model of HIE. These findings indicate that PTX can reduce the intestinal H/R injury.
